RNAC
NASDAQ · Biotechnology
Cartesian Therapeutics Inc
$6.36
-0.53 (-7.63%)
Open$6.82
Previous Close$6.88
Day High$6.82
Day Low$6.11
52W High$11.00
52W Low$5.60
Volume—
Avg Volume148.6K
Market Cap192.17M
P/E Ratio—
EPS$-5.87
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+539.8% upside
Current
$6.36
$6.36
Target
$40.66
$40.66
$22.44
$40.66 avg
$45.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.26M | 11.10M | 132.93M |
| Net Income | -151,703,098 | -465,346,926 | 3.48M |
| Profit Margin | -4,658.6% | -4,425.7% | 2.6% |
| EBITDA | -163,511,434 | -529,433,750 | 5.52M |
| Free Cash Flow | — | — | 2.68M |
| Rev Growth | -70.7% | -70.7% | -1.8% |
| Debt/Equity | 0.28 | 0.28 | 0.86 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |